Research antibodies are widely used in a variety of applications such as diagnosis, treatment monitoring, disease screening, and drug development across several industries such as healthcare and research activities. They help identify disease-related biological markers and support disease prognosis through the detection of specific antigens or biomarkers. The global Research Antibodies Market is estimated to be valued at US$ 3785.5 Bn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising demand for precision medicine and targeted therapies is expected to drive the growth of the research antibodies market over the forecast period. Precision medicine is an emerging approach for disease treatment and prevention that considers individual variability in genes, environment, and lifestyle for each person. It allows doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. Research antibodies that can identify specific protein or genetic targets play a vital role in enabling precision medicine approaches by facilitating patient stratification and selection of targeted therapies. The development of novel research antibodies against various disease biomolecular targets is expected to optimize treatment efficacy and outcomes in the field of precision medicine.
Segment Analysis
Research antibodies are broadly segmented into primary antibodies and secondary antibodies. Primary antibodies dominated the market in 2023 accounting for over 55% share. This is due to wide applications of primary antibodies in research and diagnostic procedures such as western blotting, ELISA, immunohistochemistry, immunofluorescence and flow cytometry. Primary antibodies provide specific binding to target antigens or proteins under research for detection.
Key Takeaways
The global Research Antibodies Market Growth is expected to witness high growth.
Regional analysis: North America was the largest and fastest growing market for research antibodies in 2023 owing to huge investments in R&D by biopharmaceutical companies and academic research activities in the region.
Key players operating in the research antibodies market are Zoetis Inc., Elanco Animal Health, MSD Animal Health, Benchmark Holdings, Phibro Animal Health Corporation, Intervet Inc., Norvartis, Merck Animal Health, Novartis AG, Pharmaq AS, AquaBounty Technologies, Alltech, Skretting, Nutreco, Biomin.
For more insights, read- https://www.ukwebwire.com/research-antibodies-market-trends-size-and-share-analysis-2/
Comments
0 comment